Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1042 of 5804
-
Gene therapy injection aims to save sight in rare genetic disease
Disease control Not yet recruitingThe goal of this first in human study is to evaluate the preliminary safety and tolerability of AXV-101 in participants with BBS1. The main questions it aims to answer are: * Is AXV-101 safe and tolerable to use in participants with BBS1? * To determine the therapeutic dose of A…
Phase: EARLY_PHASE1 • Sponsor: Axovia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Morning or afternoon? new study tests best time for bladder cancer drugs
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the timing of treatments plays a role in how effective the standard-of-care drugs enfortumab vedotin and pembrolizumab (EV/P) works to treat adults with advanced bladder cancer. The trial will also learn if time-of-day reduces EV/P s…
Phase: PHASE3 • Sponsor: Guliz Ozgun • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Simple mouthpiece could ease heart strain in sleep apnea patients
Disease control Not yet recruitingHeart failure with reduced ejection fraction (HFrEF) is a serious condition that limits daily activities and often leads to hospital stays and early death. Many patients with HFrEF also have obstructive sleep apnea (OSA), a common but often undiagnosed condition where breathing r…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Personalized antibiotic spray aims to stop deadly pneumonia in ICU patients
Prevention Not yet recruitingVentilator-associated pneumonia (VAP) remains the most common hospital-acquired infection worldwide, affecting up to 40% of mechanically ventilated patients and contributing to increased morbidity, prolonged hospital stays, and high mortality rates. Standard prevention strategies…
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New antibody drug firsekibart tested for scleroderma skin thickening
Disease control Not yet recruitingThis study is a single-center, single-arm, open-label, exploratory clinical trial. A total of 30 patients with diffuse cutaneous systemic sclerosis (dcSSc) will be enrolled. A historical control cohort will be established to evaluate the efficacy and safety of Firsekibart by comp…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Cuff and calm: new combo aims to boost heart health
Disease control Not yet recruitingThe main objective of this study is to demonstrate whether the combination of chronic remote ischemic conditioning and mindfulness therapy can improve myocardial flow reserve in patients with incomplete revascularization of coronary artery disease.
Phase: NA • Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New embryo genetic test aims to cut miscarriages and birth defects
Knowledge-focused Not yet recruitingThe goals of this international multicenter cross-sectional study are: 1. To provide patients with a comprehensive PGT solution capable of simultaneously detecting embryonic chromosomal aneuploidy, mosaicism, microdeletions/ microduplications, heteroploidy, and heterozygosity (L…
Sponsor: Reproductive & Genetic Hospital of CITIC-Xiangya • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New device offers hope for heart defect patients with failing circulation
Disease control Not yet recruitingThe goal of this observational clinical study look at the safety and effectiveness of the Occlutech Atrial Flow Regulator in the treatment of patients with failing Fontan circulation. This study will consist of a case series of congenital patients with Fontan failure who have bee…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
3D maps could sharpen colon cancer surgery
Diagnosis Not yet recruitingThe aim of this study is to assess the usefulness of a mathematical model of three-dimensional image process and reconstuction (3D-IPR) as a surgical planner in locally advanced colon cancer. In addition to comparing the diagnostic accuracy of this planner with that of the CT reg…
Phase: NA • Sponsor: Fundació d'investigació Sanitària de les Illes Balears • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New powder spray could stop tumor bleeding during endoscopy
Disease control Recruiting nowBackground Gastrointestinal bleeding is a common disease among the population in Taiwan, with gastrointestinal tumor bleeding accounting for 3-5% of cases. The pathophysiology of gastrointestinal tumor bleeding is unique, involving fragile surface mucosa, abnormal vascular prolif…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Engineered immune cells aim to tame Hard-to-Treat kidney disease
Disease control Not yet recruitingThis study is a single-arm, single-center, open-label, dose-escalation exploratory clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of CD19 CAR-γδ T cells. The subjects enrolled in this study are patients with relapsed/refractory autoimmune n…
Phase: EARLY_PHASE1 • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Nasal spray may prevent post-surgery delirium in seniors
Symptom relief Not yet recruitingThis study aims to determine whether, compared with placebo, the nighttime self-administration of a nasal dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in high-risk patients.
Phase: PHASE2, PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
AI doctor talks tinnitus away in landmark trial
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether a conversational artificial intelligence-based digital intervention can improve symptoms in adults with chronic subjective tinnitus. The main questions it aims to answer are: Does the Fudan Tinnitus Doctor (FTD) system redu…
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New hope for Hard-to-Treat cancers: experimental drug QLS1317 enters human trials
Disease control Not yet recruitingThe goal of this study aims to evaluate the efficacy and safety of QLS1317 in patients with MSI-H/dMMR advanced solid tumors who failed standard treatment.
Phase: PHASE1 • Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could earlier aspirin after stroke save more brains?
Disease control Not yet recruitingThis study evaluates whether early administration of low-dose aspirin (100mg) at 2 hours post-intravenous thrombolysis, compared to the standard timing of 24 hours, improves functional outcomes in patients with acute ischemic stroke. Intravenous thrombolysis is effective for very…
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Own skin cell spray could speed burn healing and cut scarring
Disease control Not yet recruitingThis study is a prospective, multicenter, real-world observational study. It aims to evaluate the effectiveness and safety of a combined therapy-autologous epidermal cell suspension followed by biological dressing (porcine xenograft) coverage-for wound repair after dermabrasion o…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New allergy shot aims to tame mugwort season in just four weeks
Disease control Recruiting nowThis study evaluates the effectiveness and safety of PollenVax, a subcutaneous allergen immunotherapy (SCIT) drug developed for the treatment of allergic rhinitis and asthma caused by mugwort (Artemisia vulgaris) pollen. PollenVax contains a recombinant form of Art v 1 - the majo…
Phase: PHASE2 • Sponsor: Kazakh National Agrarian University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Online workouts may rebuild bones in childhood cancer survivors
Disease control Not yet recruitingChildhood cancer is a rare disease but a significant cause of death in children and adolescents. The incidence of childhood cancer is 1case per 300 cases of adult cancer, but surviving to it has important sequels. Endocrine dysfunction represents one of the most common issues in …
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for tough blood cancer: experimental drug targets resistant MDS
Disease control Not yet recruitingThis study is an open-label, multicenter, non-randomized Phase Ib/II clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of BL-M11D1 for injection in patients with relapsed/refractory myelodysplastic syndromes.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Umbilical cord stem cells tested for shoulder injury
Disease control Not yet recruitingThe purpose of this study is to evaluate umbilical cord-derived mesenchymal stem cell injectables for the regeneration of partial-thickness rotator cuff tears
Phase: NA • Sponsor: Kyoung Hwan Koh • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC